ThomasDudleyKimbleMD
Obstetrics & Gynecology • Norfolk, VAGeneral Gynecology, STD Gynecology
Assistant Vice Dean of Admissions and Enrollment, Assistant Professor, Obstetrics & Gynecology, Eastern Virginia Medical School
Dr. Kimble is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Fairfax Ave
Norfolk, VA 23507Phone+1 757-625-0557Fax+1 757-625-1361
Education & Training
Eastern Virginia Medical SchoolFellowship, Reproductive Endocrinology and Infertility, 2009
Wellspan Health/York HospitalResidency, Obstetrics and Gynecology, 2002 - 2006
Howard University College of MedicineClass of 2002
Certifications & Licensure
VA State Medical License 2006 - 2026
PA State Medical License 2002 - 2006- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- Alpha Omega Alpha
Clinical Trials
- Effect of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring on Vaginal Innate and Inflammatory Biomarkers Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- 27 citationsA 1-year prospective, open-label, single-arm, multicenter, phase 3 trial of the contraceptive efficacy and safety of the oral progestin-only pill drospirenone 4 mg usi...Thomas Kimble, Anne E. Burke, Kurt T. Barnhart, David F. Archer, Enrico Colli
Contraception. 2020-01-30 - 4 citationsAcceptability of the Woman's Condom in a phase III multicenter open-label study.Beatrice A. Chen, Diana L. Blithe, Gitonga R. Muraguri, Audrey A. Lance, Bruce R. Carr
Contraception. 2019-06-01 - 26 citationsFive-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System.Stephanie B. Teal, David K. Turok, Beatrice A. Chen, Thomas Kimble, Andrea I. Olariu
Obstetrics and Gynecology. 2019-01-01
Press Mentions
Phase 3 Study Highlights Advantages of Progestogen-Only ContraceptionMay 5th, 2019
FDA Approves Five-Year Hormonal ContraceptiveOctober 16th, 2018
FDA Approves Liletta (Levonorgestrel-Releasing Intrauterine System) 52 Mg to Prevent Pregnancy for up to Five YearsAugust 6th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
